Venlo, The Netherlands, – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) announced results of operations for the third quarter and first nine months of 2012, delivering a solid performance and ongoing progress on initiatives to drive innovation and growth. In the third quarter of 2012, net sales grew 10% at constant exchange rates, or […]

Madison, WI — BellBrook Labs today announced the awarding of a Phase II SBIR grant for $850,000 from the National Heart, Lung and Blood Institute to continue development of a specialized assay plate for primary epithelial cells. The innovative plate, called the ALI Assay Plate, is designed for culturing primary airway epithelial cells at an […]

ITT Corporation (NYSE: ITT) today reported third-quarter 2012 revenue of $556 million, including 10 percent growth in organic revenue (defined as total revenue excluding foreign exchange, acquisition and divestiture impacts) compared with the 2011 third quarter. Revenue results reflected the geographic and end-market diversification of company operations. ITT’s 14 percent U.S. organic growth and 11 […]

PORTLAND, OR — FLIR Systems, Inc. (NASDAQ: FLIR) announced today that it has been awarded a contract from the U.S. Army valued at up to $88.3 million for the procurement of Domestic Response Capability (DRC) kits for use by National Guard Weapons of Mass Destruction Civil Support Teams. The DRC kit is an integrated suite […]

MANCHESTER, England — Gentronix Limited, the genotoxicity innovation and service company, is pleased to announce that it has received French research tax credit approval for years 2012 through 2014. The French Ministry of Research (Ministère de l’Enseignement Supérieur et de la Recherche) has granted the French R&D tax credit (“Crédit d’Impôt Recherche”, CIR) accreditation to […]

FARMINGDALE, N.Y., — Cemtrex, Inc. (OTC: CTEI), a leader in emissions monitoring & environmental control systems, today announced that it has acquired a stake in mobile startup Pluto Technologies Inc. “Since becoming the CEO, one of my focuses has been to diversify into new growth areas and shift away from regulatory-driven businesses that have not […]

AUSTIN, Texas, — Luminex Corporation (NASDAQ:LMNX) today announced financial results for the third quarter ended September 30, 2012. Financial and operating highlights include the following: • Completed the acquisition of GenturaDx, Inc., effective July 11, 2012. Integration activities are on-track • Consolidated third quarter revenue of $50.0 million, a 10 percent increase over the third […]

Goettingen, – Sartorius, a leading international laboratory and pharma-ceutical equipment provider, successfully closed the first nine months of 2012, with substantial gains in order intake, sales revenue and earnings. The Bioprocess Solutions Division that primarily specializes in single-use products for pharmaceutical drug manufacture performed especially well. In addition, initial consolidation of the Biohit Liquid Handling […]